PAVMED INC. — Income Charts
9 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+420.0% +$42K
$52K
Cost of Revenue↑+77.1% +$37K
$85K
Gross Profit
—
R&D↑+126.5% +$1M
$2M
D&A↓-73.9% -$51K
$18K
Operating Income↑+58.2% +$7M
$-5M
EBITDA↓-73.9% -$51K
$18K
Interest Expense↓-100.0% -$12K
$0
Interest Income↓-85.7% -$60K
$10K
Other Income/Expense↓-101.6% -$73M
$-1M
Pretax Income↓-109.9% -$67M
$-6M
Net Income↓-108.4% -$70M
$-5M
Gross Margin
—
Operating Margin↓-95717.6pts
-96880.0%
Net Margin↓-114125.8pts
-107660.0%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+7.3pts
-1.1%
ETR Foreign Differential (pp)↑+4.8pts
0.0%
Operating Lease Cost
—
Revenue YoY Variation↑+519.0pts
420.0%
Income YoY Variation
58.2%
Revenue QoQ Variation↑+1039.0pts
940.0%
Income QoQ Variation
-2.7%